Although EMP3 was considered as a positive force on the activation of the PI3K/AKT pathway in tumor cells [20.26], investigations on EMP3 and CDDP-resistant GC, as well as the key mechanisms of which EMP3 enhanced the activity of the PI3K/AKT pathway in GC cells are limited. This evidence concerns the gene AKT1 and gastric cancer.